S100A9 and cancer: First, we confirmed the presence of S100A9+ cancer cells independently of the primary source of the metastasis (Fig. 5b and Supplementary Table 14); of note, the percentage was lower in melanoma brain metastases than in lung or breast cancer (Fig. 5b).